ストックスクリーナーアプリを入手
1.43
0.00%
0.00
前日終値:
$1.43
開ける：
$1.43
24時間の取引高:
171.17K
Relative Volume:
0.53
時価総額：
$65.39M
収益：
$19.94M
当期純損益:
$-37.37M
株価収益率:
-1.375
EPS:
-1.04
ネットキャッシュフロー:
$-33.38M
1週間 パフォーマンス:
+5.93%
1か月 パフォーマンス:
+19.17%
6か月 パフォーマンス:
+16.26%
1年 パフォーマンス:
-33.80%
1日の値動き範囲:
$1.43
$1.49
1週間の範囲:
$1.30
$1.49
52週間の値動き範囲:
$0.595
$4.18
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
名前
Werewolf Therapeutics Inc
セクター
電話
617-952-0555
住所
200 TALCOTT AVENUE, WATERTOWN
HOWL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.43 | 64.48M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-08-24 | 開始されました | Wedbush | Outperform |
| 2023-06-06 | 再開されました | Jefferies | Buy |
| 2021-09-10 | 開始されました | BofA Securities | Buy |
| 2021-05-25 | 開始されました | Evercore ISI | Outperform |
| 2021-05-25 | 開始されました | H.C. Wainwright | Buy |
| 2021-05-25 | 開始されました | Jefferies | Buy |
| 2021-05-25 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Werewolf Therapeutics Inc (HOWL) 最新ニュース
Will earnings trigger a reversal in Werewolf Therapeutics Inc.Bull Run & Weekly Top Gainers Trade List - Newser
What to do if you’re stuck in Werewolf Therapeutics Inc.Price Action & Weekly High Return Forecasts - Newser
Chart based analysis of Werewolf Therapeutics Inc. trends2025 AllTime Highs & Daily Profit Focused Screening - Newser
How sentiment analysis helps forecast Werewolf Therapeutics Inc.2025 AllTime Highs & Free Technical Confirmation Trade Alerts - Newser
Research Analysts Offer Predictions for HOWL Q3 Earnings - MarketBeat
Institutional scanner results for Werewolf Therapeutics Inc.2025 Market Overview & Weekly Market Pulse Updates - Newser
Detecting price anomalies in Werewolf Therapeutics Inc. with AIMarket Movement Recap & Weekly Market Pulse Alerts - Newser
What moving averages say about Werewolf Therapeutics Inc.Day Trade & Capital Efficiency Focused Strategies - Newser
Risk adjusted return profile for Werewolf Therapeutics Inc. analyzed2025 Geopolitical Influence & Risk Controlled Daily Trade Plans - Newser
Applying Elliott Wave Theory to Werewolf Therapeutics Inc.July 2025 Spike Watch & Long-Term Investment Growth Plans - Newser
How to interpret RSI for Werewolf Therapeutics Inc. stockShort Setup & Daily Oversold Stock Bounce Ideas - Newser
Backtesting results for Werewolf Therapeutics Inc. trading strategiesJuly 2025 Weekly Recap & Fast Entry and Exit Trade Plans - Newser
What Fibonacci levels say about Werewolf Therapeutics Inc. reboundJuly 2025 Fed Impact & Advanced Technical Analysis Signals - Newser
Does Werewolf Therapeutics Inc. fit your quant trading modelJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - Newser
What momentum shifts mean for Werewolf Therapeutics Inc.Quarterly Trade Review & Safe Capital Investment Plans - Newser
Sector ETF performance correlation with Werewolf Therapeutics Inc.Breakout Watch & Weekly High Return Stock Forecasts - Newser
Is it time to cut losses on Werewolf Therapeutics Inc.Quarterly Portfolio Review & Fast Gain Stock Tips - Newser
Statistical indicators supporting Werewolf Therapeutics Inc.’s strengthPortfolio Return Report & Low Risk High Win Rate Picks - Newser
Combining price and volume data for Werewolf Therapeutics Inc.2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Will Werewolf Therapeutics Inc. bounce back from current supportJuly 2025 Gainers & Comprehensive Market Scan Reports - Newser
Can Werewolf Therapeutics Inc. hit a new high this monthWeekly Stock Report & Daily Oversold Bounce Ideas - Newser
Research Analysts Set Expectations for HOWL Q1 Earnings - MarketBeat
Regression analysis insights on Werewolf Therapeutics Inc. performanceQuarterly Risk Review & Low Volatility Stock Recommendations - Newser
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionTrade Risk Assessment & High Conviction Buy Zone Alerts - Newser
Analyzing Werewolf Therapeutics Inc. with risk reward ratio charts2025 Performance Recap & AI Driven Stock Reports - Newser
Volume spikes in Werewolf Therapeutics Inc. stock – what they meanPortfolio Performance Summary & Step-by-Step Swing Trade Plans - Newser
Risk vs reward if holding onto Werewolf Therapeutics Inc.July 2025 Update & Accurate Intraday Trading Signals - Newser
Can momentum traders help lift Werewolf Therapeutics Inc.Take Profit & Weekly High Potential Alerts - Newser
Will Werewolf Therapeutics Inc. stock benefit from AI tech trendsQuarterly Trade Review & AI Based Buy and Sell Signals - Newser
Using Bollinger Bands to evaluate Werewolf Therapeutics Inc.Insider Buying & High Conviction Investment Ideas - Newser
Applying Wyckoff theory to Werewolf Therapeutics Inc. stock2025 Macro Impact & Free Daily Entry Point Trade Alerts - Newser
Can Werewolf Therapeutics Inc. Bounce Back From Weekly Low2025 Buyback Activity & Verified Swing Trading Watchlists - beatles.ru
Werewolf Therapeutics, Inc. (HOWL) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance
What is Leerink Partnrs’ Forecast for HOWL Q3 Earnings? - Defense World
Werewolf Therapeutics Inc (HOWL) 財務データ
収益
当期純利益
現金流量
EPS
Werewolf Therapeutics Inc (HOWL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 14 '25 |
Buy |
0.98 |
162,539 |
159,288 |
6,237,482 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 13 '25 |
Buy |
0.98 |
52,974 |
51,915 |
6,074,943 |
| MPM BioVentures 2014, L.P. | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
1,963 |
2,061 |
3,208,793 |
| EVNIN LUKE | Director |
Mar 27 '25 |
Sale |
1.05 |
2,425 |
2,546 |
4,309,860 |
| GADICKE ANSBERT | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
4,386 |
4,605 |
6,718,670 |
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):